The state of California has established a $50 million collaboration over a decade with the generic drug manufacturer Civica. The goal of the collaboration is to create affordable state-branded generic insulin. Qualified individuals may obtain a 10-mL vial of generic insulin for $30 or less. California plans to provide a pack containing five prefilled 3…
Sanofi joins Lilly and Novo Nordisk in drastic insulin price reductions
Paris-based Sanofi (Nasdaq:SNY) is the fastest company to reduce insulin prices. The pharmaceutical behemoth said it would cut the list price of Lantus (insulin glargine injection) by 78%. Lantus is its most commonly prescribed insulin in the U.S. Moreover, Sanofi will implement a $35 cap on out-of-pocket expenses for users of the insulin. Sanofi has also…
Polaris Pharmaceuticals extends operations in Northern California
San Diego–based Polaris Pharmaceuticals has purchased 15 acres from the City of Vacaville, California, within the Vaca Valley Business Park. Polaris already has a contract development and manufacturing site in the city in addition to operations in San Diego and Chengdu, China. In Vacaville, the company plans to construct an additional biopharmaceutical manufacturing facility. Polaris…
California aims to produce inexpensive insulin
California Governor Gavin Newsom has signaled that the state would pursue manufacturing insulin to offer the hormone at a reduced cost to people with diabetes. “Insulin should not drain your bank account,” Newsom shared over Twitter. Newsom has also made contract manufactured insulin part of the proposed budget planning for the fiscal year 2022. The…
An inside look at Northern California’s growing biomanufacturing hub
Vacaville, Calif. is home to a burgeoning biotech hub. And there’s more to Vacaville’s biomanufacturing industry than Genentech’s presence there. “Genentech is just one of the biotech companies to open in Vacaville,” said Don Burrus, the city’s director of economic development services. “We’ve had biomanufacturers here for almost 30 years.” Genentech set up shop in…
Takeda and Capsida announce manufacturing plant investments in California
Takeda Pharmaceuticals (NYSE:TAK) has announced that it is investing $126 million to expand a production facility in Thousand Oaks, one of the largest cities in Ventura County, California. The money will support constructing a new 15,000-ft2 manufacturing facility and renovating an existing 14,000–ft2 plant. The mayor of the city, Claudia Bill-de la Peña, joined Takeda officials…